{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:13:22Z","timestamp":1791598402765,"version":"4.3.4"},"reference-count":34,"publisher":"American Diabetes Association","issue":"2","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Abnormal glucose tolerance is rising in sub-Saharan Africa. Hemoglobin A1c by itself and in combination with fasting plasma glucose (FPG) is used to diagnose abnormal glucose tolerance. The diagnostic ability of A1C in Africans with heterozygous variant hemoglobin, such as sickle cell trait or hemoglobin C trait, has not been rigorously evaluated. In U.S.-based Africans, we determined by hemoglobin status the sensitivities of 1) FPG \u22655.6 mmol\/L, 2) A1C \u2265 5.7% (39 mmol\/mol), and 3) FPG combined with A1C (FPG \u22655.6 mmol\/L and\/or A1C \u22655.7% [39 mmol\/mol]) for the detection of abnormal glucose tolerance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>An oral glucose tolerance test (OGTT) was performed in 216 African immigrants (68% male, age 37 \u00b1 10 years [mean \u00b1 SD], range 20\u201364 years). Abnormal glucose tolerance was defined as 2-h glucose \u22657.8 mmol\/L.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Variant hemoglobin was identified in 21% (46 of 216). Abnormal glucose tolerance occurred in 33% (72 of 216). When determining abnormal glucose tolerance from the OGTT (2-h glucose \u22657.8 mmol\/L), sensitivities of FPG for the total, normal, and variant hemoglobin groups were 32%, 32%, and 33%, respectively. Sensitivities for A1C were 53%, 54%, and 47%. For FPG and A1C combined, sensitivities were 64%, 63%, and 67%. Sensitivities for FPG and A1C and the combination did not vary by hemoglobin status (all P &amp;gt; 0.6). For the entire cohort, sensitivity was higher for A1C than FPG and for both tests combined than for either test alone (all P values \u2264 0.01).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>No significant difference in sensitivity of A1C by variant hemoglobin status was detected. For the diagnosis of abnormal glucose tolerance in Africans, the sensitivity of A1C combined with FPG is significantly superior to either test alone.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc14-1179","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T01:37:37Z","timestamp":1414028257000},"page":"213-219","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":43,"title":["Detection of Abnormal Glucose Tolerance in Africans Is Improved by Combining A1C With Fasting Glucose: The Africans in America Study"],"prefix":"10.2337","volume":"38","author":[{"given":"Anne E.","family":"Sumner","sequence":"first","affiliation":[{"name":"Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline K.","family":"Thoreson","sequence":"additional","affiliation":[{"name":"Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Y.","family":"O'Connor","sequence":"additional","affiliation":[{"name":"Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madia","family":"Ricks","sequence":"additional","affiliation":[{"name":"Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie T.","family":"Chung","sequence":"additional","affiliation":[{"name":"Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall K.","family":"Tulloch-Reid","sequence":"additional","affiliation":[{"name":"Tropical Medicine Research Institute, University of the West Indies, Kingston, Jamaica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay N.","family":"Lozier","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Sacks","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2014,10,22]]},"reference":[{"key":"2022031301553684700_B1","volume-title":"IDF Diabetes Atlas","author":"International Diabetes Federation","year":"2013"},{"key":"2022031301553684700_B2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.2337\/dc10-S003","article-title":"Summary of revisions for the 2010 Clinical Practice Recommendations","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031301553684700_B3","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2337\/dc13-2357","article-title":"Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA(1c) according to American Diabetes Association criteria","volume":"37","author":"Di Pino","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031301553684700_B4","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.2337\/dc10-0679","article-title":"A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"33","author":"Lorenzo","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031301553684700_B5","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/srep01671","article-title":"The distribution of haemoglobin C and its prevalence in newborns in Africa","volume":"3","author":"Piel","year":"2013","journal-title":"Sci Rep"},{"key":"2022031301553684700_B6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"2022031301553684700_B7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0035-9203(54)90101-7","article-title":"The distribution of the sickle-cell trait in East Africa and elsewhere, and its apparent relationship to the incidence of subtertian malaria","volume":"48","author":"Allison","year":"1954","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2022031301553684700_B8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1365-2141.2005.05704.x","article-title":"The frequency of the sickle allele in Jamaica has not declined over the last 22 years","volume":"130","author":"Hanchard","year":"2005","journal-title":"Br J Haematol"},{"key":"2022031301553684700_B9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ajh.2830240413","article-title":"Screening for sickle cell trait: the Veterans Administration National Sickle Cell Program","volume":"24","author":"Meyer","year":"1987","journal-title":"Am J Hematol"},{"key":"2022031301553684700_B10","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.2014.2157","article-title":"Sickle cell trait\u2014neglected opportunities in the era of genomic medicine","volume":"311","author":"Taylor","year":"2014","journal-title":"JAMA"},{"key":"2022031301553684700_B11","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"2022031301553684700_B12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2337\/dc10-1546","article-title":"A1C versus glucose testing: a comparison","volume":"34","author":"Sacks","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031301553684700_B13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1373\/clinchem.2010.148841","article-title":"Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care","volume":"57","author":"Little","year":"2011","journal-title":"Clin Chem"},{"key":"2022031301553684700_B14","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.2337\/dc11-2504","article-title":"Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance","volume":"35","author":"Bianchi","year":"2012","journal-title":"Diabetes Care"},{"key":"2022031301553684700_B15","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2337\/dc09-1524","article-title":"Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006","volume":"33","author":"Cowie","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031301553684700_B16","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.2337\/dc10-0433","article-title":"Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria","volume":"33","author":"Olson","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031301553684700_B17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/met.2014.0026","article-title":"Worse cardiometabolic health in African immigrant men than African American men: reconsideration of the healthy immigrant effect","volume":"12","author":"O\u2019Connor","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"2022031301553684700_B18","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2337\/dc11-1055","article-title":"Metabolic syndrome does not detect metabolic risk in African men living in the U.S","volume":"34","author":"Ukegbu","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031301553684700_B19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/met.2012.0114","article-title":"Triglyceride-based screening tests fail to recognize cardiometabolic disease in African immigrant and African-American men","volume":"11","author":"Yu","year":"2013","journal-title":"Metab Syndr Relat Disord"},{"key":"2022031301553684700_B20","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/dc14-S014","article-title":"Executive summary: Standards of medical care in diabetes\u20142014","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031301553684700_B21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.metabol.2008.09.017","article-title":"Validity of the reduced-sample insulin modified frequently-sampled intravenous glucose tolerance test using the nonlinear regression approach","volume":"58","author":"Sumner","year":"2009","journal-title":"Metabolism"},{"key":"2022031301553684700_B22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/152091503322641060","article-title":"MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test","volume":"5","author":"Boston","year":"2003","journal-title":"Diabetes Technol Ther"},{"key":"2022031301553684700_B23"},{"key":"2022031301553684700_B24","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/dc06-0062","article-title":"Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002","volume":"29","author":"Cowie","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031301553684700_B25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.22726","article-title":"Ethnic differences in hepatic steatosis: an insulin resistance paradox","volume":"49","author":"Guerrero","year":"2009","journal-title":"Hepatology"},{"key":"2022031301553684700_B26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood.V33.2.214.214","article-title":"32-DFP and 51-Cr for measurement of red cell life span in abnormal hemoglobin syndromes","volume":"33","author":"McCurdy","year":"1969","journal-title":"Blood"},{"key":"2022031301553684700_B27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V36.1.14.14","article-title":"Red cell lifespan in hemoglobin C disorders (with special reference to hemoglobin C trait)","volume":"36","author":"Prindle","year":"1970","journal-title":"Blood"},{"key":"2022031301553684700_B28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/clinchem\/47.2.153","article-title":"Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin","volume":"47","author":"Bry","year":"2001","journal-title":"Clin Chem"},{"key":"2022031301553684700_B29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MED.0b013e328327728d","article-title":"HbA1c: how do we measure it and what does it mean","volume":"16","author":"Little","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2022031301553684700_B30","article-title":"Multicentre evaluation of the Premier Hb9210 HbA1c analyser","author":"John","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"2022031301553684700_B31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"2022031301553684700_B32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","article-title":"Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study","volume":"2","author":"Li","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022031301553684700_B33","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(06)69701-8","article-title":"Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study","volume":"368","author":"Lindstr\u00f6m","year":"2006","journal-title":"Lancet"},{"key":"2022031301553684700_B34","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1001\/jama.1990.03440210043030","article-title":"Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes","volume":"263","author":"Haffner","year":"1990","journal-title":"JAMA"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/38\/2\/213\/622776\/dc141179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/38\/2\/213\/622776\/dc141179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T06:00:35Z","timestamp":1647151235000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/38\/2\/213\/37817\/Detection-of-Abnormal-Glucose-Tolerance-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,22]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,10,22]]},"published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc14-1179","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,22]]}}}